Gea introduces industrial-scale equipment for vaccines and blood plasma

Technology for blood plasma fractionation and vaccine production

By
PSA Desk
-
0
38
GEA
The photo shows the final formulation process. This process has two steps. An Ultra-Diafiltration and the following formulation step. The product is Immunoglobulin. (Photo: BLICKPUNKT PHOTODESIGN/Daniel Bödeker)

GEA has developed numerous innovative improvements to both blood fractionation and vaccine production and brought them to the global market by applying first-class engineering. Fractionating human blood plasma yields purified and concentrated proteins from which drugs or vaccines are then developed. The blood plasma fractionation process is complex and requires…

Choose your subscription to read more

Trial

₹ 0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*
Subscribe Now

PSA Plan 1

₹ 1000 /year
Access to the website, weekly eMail newsletter
  • ₹1,000.00 for 1 year*
Subscribe Now

PSA Plan 2

₹ 1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1500 for Year*
Subscribe Now

PSA Plan 3

₹ 2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2,000.00 for 1 year*
Subscribe Now

RELATED ARTICLESMORE FROM AUTHOR